Skip to main content

Neurogenic Bladder

1
Pipeline Programs
9
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

9 companies ranked by most advanced pipeline stage

JW Pharmaceutical
JW PharmaceuticalKorea - Seoul
1 program
1
silodosinPhase 41 trial
Active Trials
NCT01228370Completed95Est. Jan 2012
Parexel
ParexelMA - Boston
1 program
Continence Care RegistryN/A1 trial
Active Trials
NCT04924569Active Not Recruiting600Est. May 2026
ConvaTec
ConvaTecNJ - Bridgewater
1 program
Intermittent self-catheterisationN/A1 trial
Active Trials
NCT05683938Completed72Est. Apr 2023
Coloplast
ColoplastAustralia - Mulgrave
1 program
Peristeen Transanal IrrigationN/A1 trial
Active Trials
NCT04815226Unknown20Est. Dec 2023
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
SCONEN/A
Spine BioPharma
Spine BioPharmaNY - New York
1 program
SCONEN/A
SpineX
SpineXCA - Northridge
1 program
SCONEN/A1 trial
Active Trials
NCT05301335Completed126Est. May 2024
Connect Biopharma
Connect BiopharmaSAN DIEGO, CA
1 program
Vivally system stimulationN/A1 trial
Active Trials
NCT06661057Withdrawn0Est. Nov 2026
Mission Therapeutics
Mission TherapeuticsUK - Cambridge
1 program
Vivally system stimulationN/A

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
JW Pharmaceuticalsilodosin
Connect BiopharmaVivally system stimulation
SpineXSCONE
ConvaTecIntermittent self-catheterisation
ParexelContinence Care Registry
ColoplastPeristeen Transanal Irrigation

Clinical Trials (6)

Total enrollment: 913 patients across 6 trials

NCT01228370JW Pharmaceuticalsilodosin

Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder

Start: Apr 2011Est. completion: Jan 201295 patients
Phase 4Completed
NCT06661057Connect BiopharmaVivally system stimulation

Avation Electric Stimulation System for Spinal Cord Injury Neurogenic Bladder

Start: Dec 2024Est. completion: Nov 20260
N/AWithdrawn
NCT05301335SpineXSCONE

Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study

Start: May 2022Est. completion: May 2024126 patients
N/ACompleted
NCT05683938ConvaTecIntermittent self-catheterisation

GentleCath™ Air Intermittent Catheter Smartwatch Real Life Pilot Study

Start: Nov 2021Est. completion: Apr 202372 patients
N/ACompleted
NCT04924569ParexelContinence Care Registry

Continence Care Registry

Start: May 2021Est. completion: May 2026600 patients
N/AActive Not Recruiting
NCT04815226ColoplastPeristeen Transanal Irrigation

The Role of Active Administration of Peristeen Bowel Evacuation for the Management of Urinary Tract Infection

Start: Apr 2021Est. completion: Dec 202320 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

9 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.